{"nctId":"NCT00660192","briefTitle":"Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches","startDateStruct":{"date":"2008-01"},"conditions":["Refractory Migraine"],"count":25,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]},{"label":"Botox","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Botox"]}],"interventions":[{"name":"Botox","otherNames":["onobotulinumtoxinA"]},{"name":"Placebo","otherNames":["Saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adults 18 and older\n* Migraine for more than three months, that fail to respond to two or more major anti-migraine drug, meeting criteria of chronic migraine\n\nExclusion Criteria:\n\n* Age below 18\n* Pregnant or may become pregnant\n* Disease of neuromuscular junction or drugs that affect N-M junction\n* Allergy to Botox\n* Previous use of Botox for migraine by similar methodology","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Number of Days of Decrease in Pain Level Using VAS","description":"Number of days of decreased pain (2 grades or more) on Visual Analog scale. VAS ranges from 0-10, with 0 being no pain, and 10 being worst pain.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.20","spread":"5.63"},{"groupId":"OG001","value":"8.67","spread":"8.18"}]}]}]},{"type":"SECONDARY","title":"Number of Participants Satisfied With Treatment","description":"Number of Patients whose Patient global impression of change (PGIC) moderately or much improved- The PGIC is a 7 point scale that requires the clinician to assess how much the patient's pain has improved or worsened relative to a baseline state at the beginning of the intervention. and rated as:\n\nNo change (or condition has gotten worse) (1) Almost the same, hardly any change at all (2) A little better, but no noticeable change (3) Somewhat better, but the change has not made any real difference (4) Moderately better, and a slight but noticeable change (5) Better and a definite improvement that has made a real and worthwhile difference (6) A great deal better and a considerable improvement that has made all the difference (7)improved\n\nThis outcome is number of patients who chose a 6 or above on the PGIC 6 weeks after treatment.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["Pain at injection site","Cold symptoms"]}}}